The cellular origin of CHI3L1 in the injured liver and its specific mechanism of action in hepatic fibrosis remain unclear, and more in-depth studies are needed to determine whether CHI3L1 can indeed be used as a therapeutic target. The gene discussed is CHI3L1; the disease is Hepatic fibrosis.